Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-11-01A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanismsBehavioural Pharmacology · 2026-08-01The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSDClinicalTrials.gov · 2026-07-29Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.The Australian and New Zealand journal of psychiatry · 2026-07-01Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic ReviewCNS Drugs · 2026-06-14Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-13A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-06The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-25Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats.Behavioural pharmacology · 2025-12-01Griffiths et al.'s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian Perspective.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.Journal of affective disorders · 2025-11-15Psychedelics Relax Priors and Reshape Orbitofrontal DynamicsbioRxiv · 2025-09-19Active Constituents of Psilocybin Mushroom Edibles.JAMA network open · 2025-09-02Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms.American journal of ophthalmology case reports · 2025-09-01Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resourcemedRxiv · 2025-08-16Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-24630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label StudyBiological Psychiatry · 2025-04-09The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01High-quality draft genomes of ecologically and geographically diverse species.Microbiology resource announcements · 2025-02-11Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.Journal of affective disorders · 2025-01-15Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.The American journal of psychiatry · 2025-01-01: A new species from central Florida, with notes on and.Mycologia · 2025-01-01Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-04Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-04Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse: A Cautionary Tale.The Journal of clinical psychiatry · 2024-08-26What is needed for the roll-out of psychedelic treatments?Current opinion in psychiatry · 2024-07-01Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.JAMA psychiatry · 2024-06-01Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.JAMA psychiatry · 2024-06-01Ethical considerations for psychedelic-assisted therapy in military clinical settings.Journal of medical ethics · 2024-03-20New evidence for flexible psilocybin dosing in patients with treatment-resistant depression.Med (New York, N.Y.) · 2024-03-08Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometryAnalytica Chimica Acta · 2024-02-01Psilocybin Without Psychotherapy: A Cart Without a Horse?The American journal of psychiatry · 2024-01-01Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Neuroscience and biobehavioral reviews · 2023-11-01Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.Journal of psychiatric practice · 2023-09-01Introduction to the chemistry and pharmacology of psychedelic drugsAustralian Journal of Chemistry · 2023-07-04Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.Neuropharmacology · 2023-06-15Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-1496. An Open Label Study of Synthetic Psilocybin in Bipolar Type II DepressionBiological Psychiatry · 2023-04-10Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.Journal of affective disorders · 2023-04-01Assessing potential of psilocybin for depressive disorders.Expert opinion on investigational drugs · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2022-10-01The Emerging Field of Psychedelic Psychotherapy.Current psychiatry reports · 2022-10-01Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-30P388. Open Label Psilocybin Administration in Severely Treatment Resistant DepressionBiological Psychiatry · 2022-04-27The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.Proceedings of the National Academy of Sciences of the United States of America · 2021-04-27Draft Genome Sequence of the Termite-Associated "Cuckoo Fungus," () sp. TMB Strain TB5.Microbiology resource announcements · 2021-01-07Psychedelics as a treatment for disorders of consciousness.Neuroscience of consciousness · 2019-01-01High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of psychopharmacology (Oxford, England) · 2018-07-01Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical pharmacokinetics · 2017-12-01The danger of hallucinogenic mushrooms.Scottish medical journal · 1979-10-01Psilocin, Bufotenine and Serotonin: Historical and Biosynthetic ObservationsJournal of Psychedelic Drugs · 1979-01-01